LoginRegister
    Cancer Causing Asbestos Threat: Sri Lanka halts imports of Johnson & Johnson Baby PowderCancer Causing Asbestos Threat: Sri Lanka halts imports of Johnson & Johnson Baby Powder
    Natco Pharma submits new drug application with USFDA for generic Ibrutinib tabletsNatco Pharma submits new drug application with USFDA for generic Ibrutinib tablets
    Thailand: Three Companies try to patent medical marijuana, applications suspendedThailand: Three Companies try to patent medical marijuana, applications suspended
    SUGAM registration Mandatory: CDSCO directs State drugs controllers to enforce ruleSUGAM registration Mandatory: CDSCO directs State drugs controllers to enforce rule
    Torrent Pharma Q3 profit jumps over four fold to Rs 246 croreTorrent Pharma Q3 profit jumps over four fold to Rs 246 crore
    Natco Pharma launches Valsartan Sacubitril tablets in India under brand name VALSACNatco Pharma launches Valsartan Sacubitril tablets in India under brand name VALSAC
    Lambda Therapeutic acquires US based Novum Pharmaceutical Research ServicesLambda Therapeutic acquires US based Novum Pharmaceutical Research Services
    Pfizer quarterly profit in line, touts pipeline of future productsPfizer quarterly profit in line, touts pipeline of future products
    Undeterred by Sanofi stumble, Takeda takes similar path with dengue shotUndeterred by Sanofi stumble, Takeda takes similar path with dengue shot
    NPPA fixes retail price of 29 drug formulations including BP, Cholesterol, pain medications; DetailsNPPA fixes retail price of 29 drug formulations including BP, Cholesterol, pain medications; Details
    Strides to exit investment in Arrow Pharma for over Rs 2000 croreStrides to exit investment in Arrow Pharma for over Rs 2000 crore
    U.S. senator asks J&J for documents on talc, baby powder safetyU.S. senator asks J&J for documents on talc, baby powder safety
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X